跳至主要内容
临床试验/ITMCTR1900002679
ITMCTR1900002679尚未招募4 期

Postmarket research for two classical formulae of Chinese medicine based on an overarching design

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. Diagnosis of eczema/atpoic dermatitis;
  • 2. Diagnosis of dampness pattern in Chinese Medicine;
  • 3. aged 18-70 years;
  • 4. 1% < BSA < 10%;
  • 5. 1 <= IGA <= 3;
  • 6. Signed Informed consent.

排除标准

  • 1. Those with any uncontrolled cardiovascular, respiratory, digestive, urinary, hematological disease, known cancer or mental disease.
  • 2. Those who has ever used Huoxiang Zhengqi Oral Liquid for treating eczema/atopic dermatitis.
  • 3. Anyone allergic to any medicine or ingredients used in this study.
  • 4. Examination result shows that ALT or AST level exceeded 2 times of the higher range value; either total bilirubin or BUN level exceeded 1.5 times of the higher range value in screening period.
  • 5. Those who are pregnant, lactating, or who plan to become pregnant within 3 months.
  • 6. Medication used:
  • (1) Systemic therapy with immunomodulatory or immunosuppressive agents (including tripterygium wilfordii) within 4 weeks;
  • (2) Topical or systematic therapy with antibiotics or antihistamines within 2 weeks;
  • (3) Phototherapy (such as PUVA, UVA or UVB) within 4 weeks;
  • (4) Topical therapy with immunomodulator within 2 weeks;
  • (5) Topical or systematic used any over-the-counter drugs within a week.
  • 7. Those who are participating in any clinical trial or had participated in clinical trial within a month.
  • 8. Those who are considered not appropriate to participate in this trial.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验